The Battle Against Childhood Cancers

By Admin
Written by Adam Groff Fortunately, as technology advances, so does the fight against childhood cancer. So, how are the advancements in healthcare tech...

Written by Adam Groff

 

Fortunately, as technology advances, so does the fight against childhood cancer. So, how are the advancements in healthcare technology improving patient outcomes and which childhood cancers are still troubling doctors?

Recent Advancements

According to Stephen Sallan, MD, the Chief of Staff Emeritus at the Dana-Farber Cancer Institute, one of the leading pediatric cancer centers in the country, the latest data shows that the survival rate for acute lymphoblastic leukemia, the most common form of childhood cancer, is roughly 90%.

Considering that percentage is the highest its been in recent years, it’s obvious doctors are discovering breakthroughs in childhood cancer treatment.

Here are just a few more reasons the medical world is hopeful in terms of advancements in pediatric cancer treatment.

Fewer Side Effects– With all the radiation treatments and painful procedures children with cancer must go through, it’s reassuring to know doctors are finding ways to lessen the side effects.

For example, children with Hodgkin lymphoma are receiving lower doses of radiation, yet seeing the same positive results due to advancements with the way in which the radiation is administered.

Improved Quality of Life– For those younger patients receiving chemotherapy, more than 85% of cancer therapy can now be done in an outpatient setting all do to recent developments in outpatient procedures. So, children no longer have to be admitted to the hospital for cancer therapy.

Detection– One of the main causes of cancerous cells returning is the inability to detect trace amount of leukemia and other leading childhood cancers. But, with the recent technological advancements in cancer screening equipment, doctors can better locate cancerous cells before they have a chance to spread.

Personalized Therapy – Cancer takes hold in different forms from one young patient to the next. Because of this, specialized cancer therapies that target cell alterations specific to each patient are being used everyday. For younger patients especially, this advanced form of therapy will no longer be as damaging to healthy tissue and cells.

Rare Cancers

Although recent healthcare advancements are tackling common childhood cancers while also giving children the quality of life they deserve, there are still some cancers out there that are troubling the medical field.

Rare cancers commonly found in adults are beginning to show up in child patients. According to the Children’s Cancer and Leukemia Group, these cancers make up for 1 and 30 of all childhood cases.

Digestive system, adrenal gland, and thyroid cancer once found only in adults are becoming more and more common in younger patients. So are neck and head cancers like nasopharyngeal and meningioma.

In addition, cancerous tumors specific to infants and younger patients are also on the rise. Malignant rhabdoid and melanotic neuroectodermal tumors are becoming more of a concern to doctors as the number of cases increase.

Regardless of how rare some childhood cancers are, it’s important to keep in mind that the cancers that were once considered rare are now commonly treated.

Hopefully every new form of childhood cancer that comes about will be met and beat by the next technological advancement in healthcare.

 

About the Author

Adam Groff is a freelance writer and creator of content. He writes on a variety of topics including personal health, disposable diapers, and family.

Share
Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma